At CincyBio 2009 scientific advances meet the laws that govern them in a thought-provoking one day conference.
Billed as "The Bioscience Event for Innovators and Intellectual Property Professionals," CincyBio 2009 will be 7:30 a.m.-4:30 p.m. Nov. 4 at Kingsgate Marriott Conference Hotel at the University of Cincinnati.
CincyBio 2009 seeks to expose students, lawyers, and industry professionals to the latest biotech innovations and their legal implications. Speakers represent a cross-section of companies and institutions from around town and across the globe, including Procter & Gamble, BioOhio, Children’s Hospital, UC, Bexion, and Ethicon Endo-Surgery.
Academia and industry will share the stage at CincyBio where panelists will discuss collaborations among universities and companies. Attendees can also attend panel discussions on pharmaceuticals and biomedical devices while Sam Han, a University of Dayton professor, will speak on policy issues surrounding patenting of the breast cancer gene.
The goal is for participants to gain local and global perspective of the growing bio-science industry and the region's advancing role. In a lunchtime keynote, John F. Lewis, Jr. of BioOhio will present on the state of Ohio’s life science industry. Bringing the global perspective, Cyra Nargolwalla, a partner at Cabinet Plasseraud in Paris, will close the conference with a presentation on biotech patenting in Europe.
CincyBio 2009 is co-hosted by the University of Cincinnati, Children’s Hospital, CincyIP (Cincinnati Intellectual Property Law Association), Cincinnati Chapter of the Licensing Executive Society, and BIOSTART.
Written by: Elena Stevenson
Source: CincyBio 2009, Stipkala LLP